TY - JOUR
T1 - Quality evaluation of solid organ transplant in Italy for the period 2000 to 2002 data from the National Transplant Center
AU - Taioli, E.
AU - Venettoni, S.
AU - Pretagostini, R.
AU - Roggero, S.
AU - Scalamogna, M.
AU - Mattucci, D. A.
AU - Costa, A. N.
N1 - Funding Information:
The study was partially supported by grants of the Italian Ministry of Health (COBM/F1 and PB-0026). The Quality Project Group included (kidney): Az Osp OIRMS—Sant’ Anna, Torino (R. Coppo); Osp Maggiore della Carità, Novara (E. Turello); Policlinico, Modena (A. Albertazzi); Az Osp “Vito Fazzi,” Lecce (E. Buongiorno); Az Osp Consorziale Policlinico, Bari (F.P. Schena, F.P. Selvaggi); Pres Ospedal Spedali Civili, Brescia (S. Sandrini); Ospedale S Bartolo, Vicenza (S. Chiaramente); Ospedale Ca’ Fondello, Treviso (G. Calconi); A.O. Verona, Verona (L. Boschiero); Az Ospedale S Martino e Cl Iniv Conv, Genova (U. Valente); A.O. Perugia—Silvestrini, Perugina (U. Boncristiani); Ospedale S Eugenio, Roma (C. Cascinai); Ospedale Pediatrico Bambino Gesù, Roma (G. Rizzoni); Policlinico A Gemelli e CIC, Roma (M. Castagneti); Az Policlinico Umberto I, Roma (P. Berloco); Ospedale Regionale S Salvatore, L’Aquila (A. Famulari); Azienda Universitaria Policlinico Federico II, Napoli (M.L. Santangelo); Ospedale Civile Dell’Annunziata, Cosenza (A. Mino); Az Osp Bianchi Melacrino Morelli, Reggio Calabria (F. Bartolomeo); Az Osp Pugliese, Catanzaro (G. Merando); Ospedale SS Annunziata, Sassari (G. Sorba); A.O. Brotzu (Ospedale San Michele), Cagliari (P. Altieri); Azienda Ospedaliera, Padova (E. Ancona); S. Orsola—Malpigli, Bologna (S. Stefoni); Azienda Ospedaliera, Verona (L. Boschiero); Osp Riuniti—(Op Maggiore), Parma (L. Arisi); Az Osp San Giovanni Battista, Torino (Segoloni); Az Osp Pisana, Pisa (F. Mosca); Osp Riuniti (Pol. Le Scotte), Siena (M. Carmellini); Az Ospedaliera Careggi, Firenze (M. Salvatori); Ospedali Riuniti, Bergamo (G. Remuzzi); Ospedale Ca’ Granda Riguarda, Milano (G. Civati); Maggiore Policlinico, Milano (L. Berardinelli); Policlinico Universitario, Udine (F. Bresaola); Policlinico Universitario, Catania (G. Veroux); Policlinico Universitario, Palermo (M. Romano); Ospedale Policlinico San Matteo, Pavia (T. Rampino); Irccs S. Raffaele, Milano (A. Secchi); Ismett Partnership Dip Interazienda, Palermo (B. Gridelli); Ospedale di Circolo e Fondazione Macchi, Varese (D. Donati); Ospedale Civico, Palermo (V. Saracino). (Heart): A.O. San Giovanni Battista, Torino (A.M. Calafiore, F. Patanè); OIRM Sant’Anna, Torino (Abbruzzese); Sant’Orsola Malpigli, Bologna (R. Di Bartolomeo, G. Arpesella); Ospedale Ca’ Granda Riguarda, Milano (M. Frigerio); Azienda Ospedaliera, Padova (A. Gambino); Az Osp S. Camillo—Forlanini, Roma (F. Musumeci); Osp Pediatrico Bambino Gesù, Roma (Parisi); Az Policlinico Umberto I, Roma (M. Toscano); Osp S Camillo De’ Lellis, Chieti (G. Di Giammarco); Az Osp Monadi, Napoli (M. Cotrufo, C. Macello); Osp Policlinico Ferrarotto, Catania (M. Abbate, M. Russo); Az Osp G. Brotzu, Cagliari (F. Meloni); Osp Policlinico S Matteo, Pavia (M. Vigano); Policlinico Universitario, Udine (U. Livi); Ospedali Riuniti, Bergamo (P. Terrazzi); Azienda Ospedaliera, Verona (G. Faggian); Ospedali Riuniti (Pol. Le Scotte), Siena (M. Maccheroni); Az Osp Consorziale Policlinico, Bari (L. De Luca Tuputi Schifosa). (Liver): Az Osp Padova (D. D’Amico); Az Osp Cardarelli, Napoli (O. Cuomo); Az Osp Cardarelli, Napoli (A. Calice); Ist Regina Elena IFO, Roma (E. Santoro); Policlinico A Gemelli, Roma (M. Castagneto); Clinica Chir Az Osp Consorziale Policlinico, Bari (V. Memeo); Clinica Chir Osp S. Eugenio, Roma (C.U. Cascinai); Az Osp Policlinico Umberto I Roma (P. Berloco); Az Osp San Martino, Genova (U. Valente); Chirurgia e Tx Az Osp Pisana, Pisa (F. Filippini); Az Osp Giovanni Battista, Torino (M. Salizzoni); Policlinico Universitario, Udine (F. Bresadola); Centro Tx fegato Riguarda, Milano (L. De Carlis); Centro Tx fegato, Milano (V. Mazzaferro); Osp Maggiore Policlinico, Milano (L. Rainero Fassati); Ist Mediterr Per i Tx—ISMETT A.O. Civico, Palermo (B. Gridelli); Centro Tx fegato Bergamo Az Osp Riuniti, Bergamo (Colledan); U.O. 1° Chir Clinicizzata Az Osp Verona, Verona (C. Cordiano); Az Osp S Orsola, Bologna (A. Pinna); Centro Trapianti Fegato Policlinico, Modena (G. Gerunda).
PY - 2005/12
Y1 - 2005/12
N2 - Background. As part of the increased need for transparency and disclosure of information in health care, the Italian Minister of Health has commissioned the Superior Institute of Health to study health outcomes for several procedures, among which is solid organ transplants. We herein report the results of a quality evaluation of solid organ transplants and on the relationship between hospital volume of activity and outcomes, using the data routinely collected by the National Transplant Center during the period 2000 to 2002. Methods. We collected and analyzed all the information on solid organ transplants between 2000 and 2002, along with clinical information before and after transplant. Multivariate survival analysis was performed to adjust the follow-up data for the complexity of the cases. Correlation graphs are presented that assess the association between the number of transplants and the adjusted 1-year survival of both the organ and the patient. Results. One-year survival was 92.4% for kidney, 77.8% for liver, and 83.9% for heart. Patient survival was 97.0%, 84.1%, and 83.9%, respectively. A negative correlation was observed between the number of transplants performed by each center and 1-year survival of the organ. Conclusions. Our study indicated that survival after organ transplants in Italy is good and that hospital quality, indirectly measured through survival, overlaps that observed in other Western countries.
AB - Background. As part of the increased need for transparency and disclosure of information in health care, the Italian Minister of Health has commissioned the Superior Institute of Health to study health outcomes for several procedures, among which is solid organ transplants. We herein report the results of a quality evaluation of solid organ transplants and on the relationship between hospital volume of activity and outcomes, using the data routinely collected by the National Transplant Center during the period 2000 to 2002. Methods. We collected and analyzed all the information on solid organ transplants between 2000 and 2002, along with clinical information before and after transplant. Multivariate survival analysis was performed to adjust the follow-up data for the complexity of the cases. Correlation graphs are presented that assess the association between the number of transplants and the adjusted 1-year survival of both the organ and the patient. Results. One-year survival was 92.4% for kidney, 77.8% for liver, and 83.9% for heart. Patient survival was 97.0%, 84.1%, and 83.9%, respectively. A negative correlation was observed between the number of transplants performed by each center and 1-year survival of the organ. Conclusions. Our study indicated that survival after organ transplants in Italy is good and that hospital quality, indirectly measured through survival, overlaps that observed in other Western countries.
UR - http://www.scopus.com/inward/record.url?scp=29544446131&partnerID=8YFLogxK
U2 - 10.1016/j.transproceed.2005.11.017
DO - 10.1016/j.transproceed.2005.11.017
M3 - Article
C2 - 16387069
AN - SCOPUS:29544446131
SN - 0041-1345
VL - 37
SP - 4163
EP - 4169
JO - Transplantation Proceedings
JF - Transplantation Proceedings
IS - 10
ER -